China has administered over 800 million doses of Covid-19 vaccines
That's just five days after the figure reached 700 million and 74 days after vaccinations exceeded the 100 million dose threshold on March 27.
Chinese company produces new mask that can kill coronavirus
The mask can be used repeatedly about 60 times because of the long effective action time of the copper ions in the fiber.
OPPO launches Covid-19 companion diagnostics research platform
At today's OPPO INNO DAY 2020, OPPO announced the launch of a companion diagnostic research platform for the Covid-19.
Recovered Hong Kong man, 33, re-infected with new coronavirus in world's first case
A patient recovered from novel coronavirus pneumonia has tested positive again after returning to Hong Kong from Europe. A team from the Department of Microbiology at the University of Hong Kong confirmed that the patient was infected with the novel coronavirus for the second time, the first such case in the world.
China officially launched emergency use of Covid-9 vaccine on July 22
China has officially launched the emergency use of the Covid-9 vaccine on July 22, Zheng Zhongwei, director of the National Health Commission’s Science and Technology Development Centre and head of the State Council's Joint Prevention and Control Mechanism Research and Development Task Force on Vaccine, said on today's CCTV program.
China-made Covid-19 vaccine expected to be available by end of Dec and costs less than $144 for two doses
China National Pharmaceutical Group (Sinopharm) chairman Liu Jingzhen said its inactivated coronavirus vaccine will be ready for approval after phase III clinical trials and is expected to be on the market by the end of December this year.
China CDC expert: Beijing could see zero reported Covid-19 cases in a week
Optimistically, Beijing could see a clearing of reported Covid-19 cases in a week or so, the Chinese CDC Chief epidemiologist Wu Zunyou said today.
China's first new coronavirus mRNA vaccine approved to start clinical trials
The new coronavirus mRNA vaccine candidate (ARCoV) developed by the Institute of Military Medical Sciences of the Chinese Academy of Military Sciences has been approved for clinical trials, which is the first mRNA vaccine approved for clinical trials in China.
Another recombinant protein vaccine for coronavirus from China has entered clinical trials
Recently, the coronavirus recombinant protein vaccine, jointly developed by the Institute of Microbiology of the Chinese Academy of Sciences and Anhui Zhifei LongKema Biopharmaceutical Co.
Chinese team makes breakthrough in coronavirus antibody research
A Chinese team discovered the first efficient neutralizing monoclonal antibodies targeting the N-terminal domain of the spine protein, marking a major breakthrough in the study of novel coronavirus antibodies, according to